Bevacizumab Plus Modified FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma, Single-arm, Phase II Study

Conditions:   Mucinous Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer Intervention:   Drug: Bevacizumab + modified FOLFIRINOX Sponsor:   Yonsei University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials